Journal article
Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells
Journal of ocular pharmacology and therapeutics, Vol.36(1), pp.42-55
01/2020
DOI: 10.1089/jop.2018.0146
PMCID: PMC7476392
PMID: 31414943
Abstract
Widely used approaches for retinal disease modeling and
therapeutic testing can be augmented by using tissue-engineered scaffolds with a precise 3-dimensional structure. However, the materials currently used for these scaffolds are poorly matched to the biochemical and mechanical properties of the
retina. Here, we create biopolymer-based scaffolds with a structure that is amenable to retinal tissue engineering and modeling.
Optimal two-photon polymerization (TPP) settings, including laser power and scanning speed, are identified for 4 methacrylated biopolymer formulations: collagen, gelatin, hyaluronic acid (HA), and a 50/50 mixture of gelatin/HA, each with methylene blue as a photoinitiator. For select formulations, fabrication accuracy and swelling are determined and biocompatibility is evaluated by using human induced pluripotent stem cells and rat postnatal retinal cells.
TPP is feasible for each biopolymer formulation, but it is the most reliable for mixtures containing gelatin and the least reliable for HA alone. The mean size of microscaffold pores is within several microns of the intended value but the overall structure size is several times greater than the modeled volume. The addition of HA to gelatin scaffolds increases cell viability and promotes neuronal phenotype, including Tuj-1 expression and characteristic morphology.
We successfully determined a useful range of TPP settings for 4 methacrylated biopolymer formulations. When crosslinked, these extracellular matrix-derived molecules support the growth and attachment of retinal cells. We anticipate that when combined with existing patient-specific approaches, this technique will enable more efficient and accurate retinal disease modeling and therapeutic testing
than current techniques allow.
Details
- Title: Subtitle
- Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells
- Creators
- Arwin Shrestha - Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Roy J. Carver College of Medicine, The University of Iowa, Iowa City, IowaBrittany N Allen - Roy J. Carver Department of Biomedical Engineering, College of Engineering, The University of Iowa, Iowa City, IowaLuke A Wiley - Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Roy J. Carver College of Medicine, The University of Iowa, Iowa City, IowaBudd A Tucker - Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Roy J. Carver College of Medicine, The University of Iowa, Iowa City, IowaKristan S Worthington - Institute for Vision Research, Department of Ophthalmology and Visual Sciences, Roy J. Carver College of Medicine, The University of Iowa, Iowa City, Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of ocular pharmacology and therapeutics, Vol.36(1), pp.42-55
- DOI
- 10.1089/jop.2018.0146
- PMID
- 31414943
- PMCID
- PMC7476392
- NLM abbreviation
- J Ocul Pharmacol Ther
- ISSN
- 1080-7683
- eISSN
- 1557-7732
- Publisher
- United States
- Grant note
- P30 EY025580 / NEI NIH HHS
- Language
- English
- Date published
- 01/2020
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Iowa Neuroscience Institute; Chemical and Biochemical Engineering; Ophthalmology and Visual Sciences
- Record Identifier
- 9984070560102771
Metrics
34 Record Views